Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000544063 | SCV000659142 | pathogenic | RASopathy | 2023-08-17 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with arginine, which is basic and polar, at codon 102 of the SOS1 protein (p.Pro102Arg). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of Noonan syndrome (PMID: 19953625, 32981126). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 477721). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SOS1 protein function. For these reasons, this variant has been classified as Pathogenic. |
Gene |
RCV001591305 | SCV001824905 | likely pathogenic | not provided | 2021-04-19 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are often considered pathogenic (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 32981126, 20461756, 24803665, 19953625) |
Genome- |
RCV002467898 | SCV002763593 | likely pathogenic | Noonan syndrome 4 | criteria provided, single submitter | clinical testing |